Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases

• Egile Nagusiak: Rinda Devi Bachu (Egilea), Pallabitha Chowdhury (Egilea), Zahraa H. F. Al-Saedi (Egilea), Pradeep K. Karla (Egilea), Sai H. S. Boddu (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2018-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Ocular drug delivery is challenging due to the presence of anatomical and physiological barriers. These barriers can affect drug entry into the eye following multiple routes of administration (e.g., topical, systemic, and injectable). Topical administration in the form of eye drops is preferred for...